Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

252 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Analytical Advances in the Ex Vivo Challenge Efficacy Assay.
Richardson-Harman N, Parody R, Anton P, McGowan I, Doncel G, Thurman AR, Herrera C, Kordy K, Fox J, Tanner K, Swartz G, Dezzutti CS. Richardson-Harman N, et al. Among authors: anton p. AIDS Res Hum Retroviruses. 2017 Apr;33(4):395-403. doi: 10.1089/AID.2016.0073. Epub 2016 Dec 16. AIDS Res Hum Retroviruses. 2017. PMID: 27841671 Free PMC article. Clinical Trial.
Rectal microbicides.
McGowan I, Anton P. McGowan I, et al. Among authors: anton p. Curr Opin HIV AIDS. 2008 Sep;3(5):593-8. doi: 10.1097/COH.0b013e32830891cf. Curr Opin HIV AIDS. 2008. PMID: 19373027
Pharmacokinetics and pharmacodynamics in HIV prevention; current status and future directions: a summary of the DAIDS and BMGF sponsored think tank on pharmacokinetics (PK)/pharmacodynamics (PD) in HIV prevention.
Romano J, Kashuba A, Becker S, Cummins J, Turpin J, Veronese F; Antiretroviral Pharmacology In HIV Prevention Think Tank Participants. Romano J, et al. AIDS Res Hum Retroviruses. 2013 Nov;29(11):1418-27. doi: 10.1089/aid.2013.0122. Epub 2013 May 22. AIDS Res Hum Retroviruses. 2013. PMID: 23614610 Free PMC article. Review.
Reverse transcriptase inhibitors as potential colorectal microbicides.
Herrera C, Cranage M, McGowan I, Anton P, Shattock RJ. Herrera C, et al. Among authors: anton p. Antimicrob Agents Chemother. 2009 May;53(5):1797-807. doi: 10.1128/AAC.01096-08. Epub 2009 Mar 2. Antimicrob Agents Chemother. 2009. PMID: 19258271 Free PMC article.
The pharmacokinetics, pharmacodynamics, and mucosal responses to maraviroc-containing pre-exposure prophylaxis regimens in MSM.
McGowan I, Wilkin T, Landovitz RJ, Wu C, Chen Y, Marzinke MA, Hendrix CW, Richardson P, Eshleman SH, Andrade A, Chege W, Anderson PL, McCauley M, Farley J, Mayer KH, Anton P, Brand RM, Cranston RD, Gulick R. McGowan I, et al. Among authors: anton p. AIDS. 2019 Feb 1;33(2):237-246. doi: 10.1097/QAD.0000000000002038. AIDS. 2019. PMID: 30557160 Free PMC article. Clinical Trial.
Implications of HIV PrEP trials results.
Veronese F, Anton P, Fletcher CV, DeGruttola V, McGowan I, Becker S, Zwerski S, Burns D; Workshop Organizing Committee. Veronese F, et al. Among authors: anton p. AIDS Res Hum Retroviruses. 2011 Jan;27(1):81-90. doi: 10.1089/AID.2010.0226. Epub 2010 Dec 12. AIDS Res Hum Retroviruses. 2011. PMID: 20969483 Free PMC article.
252 results